AFFERENT PHARMACEUTICALS INC / MERCK & CO / THIRD ROCK VENTURES LLC / TEKLA CAPITAL MANAGEMENT LLC / NEW LEAF VENTURE PARTNERS / DOMAIN ASSOCIATES LLC / A M PAPPAS & ASSOCIATES / Acquisition / Private / £859m

Financials

Transaction Value-

Consideration Type-

Capital Owned-

Capital Bid For-

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

Afferent Pharmaceuticals

Merck & Co

A M Pappas & Associates

Domain Associates

New Leaf Venture Partners

Tekla Capital Management

Third Rock Ventures

Sources